TSHR antagonist S37a
目录号: PL12487 纯度: ≥98%
CAS No. :2143452-20-2
商品编号 规格 价格 会员价 是否有货 数量
PL12487-5mg 5mg ¥5934.55 请登录
PL12487-10mg 10mg ¥9890.91 请登录
PL12487-25mg 25mg ¥19163.64 请登录
PL12487-50mg 50mg ¥29672.73 请登录
PL12487-100mg 100mg ¥44509.09 请登录
PL12487-200mg 200mg 询价 询价
PL12487-500mg 500mg 询价 询价
PL12487-10mM*1mLinDMSO 10mM*1mLinDMSO ¥6008.73 请登录
Medlife所售产品仅用于科学研究(非临床研究),非药品不可食用,不可用于人体或动物的临床诊断和治疗,我们不为个人提供产品及服务。产品COA等资料,可至下方“质量控制”中下载。
中文名称
TSHR antagonist S37a
中文别名
化合物 T13217
英文名称
TSHR antagonist S37a
英文别名
TSHR antagonist S37a;CID 156588665;5,9-Methanothiazolo[5',4':5,6]thiopyrano[2,3-f]isoindole-2,6,8(7H)-trione, 3,4a,5,5a,8a,9,9a,10-octahydro-7,10-diphenyl-, (4aS,5S,5aR,8aR,9R,9aS,10R)-;TSHR antagonist S37a,TSHR antagonist S-37a
Cas No.
2143452-20-2
分子式
C25H19N2O3S2
分子量
459.56
包装储存
Powder -20°C 3 years;4°C 2 years
产品详情
TSHR antagonist S37a 是一个高选择性的促甲状腺激素受体 TSHR 拮抗剂,具有研究格雷夫斯眼窝病的潜力 。
生物活性
TSHR antagonist S37a is a highly selective thyrotropin receptor (TSHR) antagonist, with potential for the treatment of Graves orbitopathy.
性状
Solid
IC50 & Target[1][2]
TSHR
体外研究(In Vitro)
TSHR antagonist S37a exhibits inhibition activity for TSHR, with IC50s of 40 μM and approximately 20 μM for mTSHR and hTSHR, respectively, in HEK293 cells.
TSHR antagonist S37a not only inhibits the TSHR activation by thyrotropin itself but also activation by monoclonal TSAb M22 (human), KSAb1 (murine), and the allosteric small-molecule agonist C2.
has not independently confirmed the accuracy of these methods. They are for reference only.
体内研究(In Vivo)
TSHR antagonist S37a also inhibits cyclic adenosine monophosphate formation by oligoclonal TSAb, which are highly enriched in GO patients sera.
TSHR antagonist S37a (10 mg/kg ;i.g.) displays no toxicity and a remarkable 53% oral bioavailability in mice.
has not independently confirmed the accuracy of these methods. They are for reference only.
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
Powder -20°C 3 years;4°C 2 years
参考文献
[1]. Marcinkowski P, et al. A New Highly Thyrotropin Receptor-Selective Small-Molecule Antagonist with Potential for the Treatment of Graves Orbitopathy. Thyroid. 2019 Jan;29(1):111-123.
溶解度数据
In Vitro: DMSO : 100 mg/mL (217.12 mM; Need ultrasonic)配制储备液
搜索质检报告(COA)

1:一般建议:溶解度为Medlife测试数据,可能与文献描述存在差异。这是由于生产工艺和批次不同产生的正常现象。为了使其更好的溶解,请用37℃加热试管并在超声波水浴中震动片刻。不同批次产品溶解度各有差异,仅做参考,具体以实验方案为准。

2:储存条件:粉末-20°C一般情况可以保存3年,溶于溶剂-80°C一般情况可以保存1年。不同产品及不同批次产品可能存在差异,请细致阅读产品信息,并辅助参考相关文献描述。

The molarity calculator equation
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
The dilution calculator equation
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2